Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.90, $0.69 better than the analyst estimate of $0.21. Revenue for the quarter came in at $110.71 million versus the consensus estimate of $87.61 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.